Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical system following one, two, or three topical system applications and compare to the pharmacokinetics of ZTlido.

Key facts

Study ID

NCT04819581

Run by

Scilex Pharmaceuticals, Inc.

People needed

15

Starts

2019-08-03

Expected to finish

2019-08-27

Last updated by the study team

2021-03-29

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

Where it is running

• AXIS Clinicals — Dilworth, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.